Put Torsades Risk With Cholinesterase Inhibitors in Perspective
October 2022
You’ll hear about an increased risk of QT prolongation and torsades with cholinesterase inhibitors (donepezil, etc).
These meds are commonly prescribed for Alzheimer’s or Parkinson’s dementia. About 3 million Rxs are dispensed in Canada each year.
Cholinesterase inhibitors already have warnings about bradycardia. But now Health Canada is expanding the warnings to include the risk of QT prolongation and torsades.Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive